SecBot SecBot
144 ·Filed Oct 14, 2026

CARL

CARLSMED, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed12d 11h ago SEC0001959173-26-007372
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a mandatory sell-to-cover transaction for tax purposes, not a discretionary insider sale. No material signal about the company's outlook. Monitor for any future discretionary Form 4 filings by insiders.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
CARL ▲ +3.32% at T+5d
NEUTRAL call +3.32% · α vs SPY +2.87% · entry $13.85 → $14.31
Next anchor: T+20d in 15d
Latest observation: T+7 -4.60% FF3 residual α
Entry = T+0 close
Oct 14, 2026
via day close
T+1d
+0.72%
call +0.72% · α +0.44%
$13.95
settled 12d ago
T+5d
+3.32%
call +3.32% · α +2.87%
$14.31
settled 6d ago
T+20d
Pending
in 15d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Former officer Leonard M. Greenstein filed a Form 144 notice to sell 4,136 shares of Carlsmed common stock, with an estimated aggregate market value of approximately $57,872. The sale is described as being solely to cover tax withholding obligations arising from the settlement of a vested equity award distribution. This is a routine sell-to-cover transaction, not a discretionary insider sale.

Key Facts

  • Filer: Leonard M. Greenstein, a former officer of Carlsmed, Inc.
  • Proposed sale: 4,136 shares of common stock.
  • Estimated aggregate market value: $57,872.15.
  • Reason: Sale to cover tax obligation from settlement of a vested equity award distribution.
  • Broker: Fidelity Brokerage Services LLC.
  • Filing date: October 14, 2026; proposed sale date also October 14, 2026.

Financial Impact

Approximately $57,872 in shares to be sold, representing a small fraction of the company's market cap.

dilution

Risk Factors

  • None from this filing; routine tax-related sale.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007372
Document: 0001959173-26-007372-index.html0001959173-26-007372
Document: 0001959173-26-007372.txt0001959173-26-007372
6 reports for CARL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CARL — sortable, filterable
TypeNow
Oct 14, 2026
12d ago
144
NEUTRAL ★ 2/10
$13.85awaiting T+20—$14.91 (+7.65%)
Sep 30, 2026
26d ago
8-K
NEUTRAL ★ 4/10
$14.07awaiting T+20—$14.91 (+5.97%)
Sep 28, 2026
28d ago
Press Release
NEUTRAL ★ 4/10
$14.18 $14.91▲ +5.15%▲ +5.18%$14.91 (+5.15%)
Sep 15, 2026
5w ago
Insider Buy
BULLISH ★ 6/10
$15.31 $14.47▼ −5.49%▼ −8.66%$14.91 (−2.61%)
Aug 24, 2026
9w ago
EFFECT
NEUTRAL ★ 3/10
$15.80 $15.42▼ −2.41%▼ −3.72%$14.91 (−5.63%)
Jul 22, 2026
13w ago
Press Release
NEUTRAL ★ 1/10
$11.00 $16.50▲ +50.00%▲ +46.69%$14.91 (+35.55%)
Showing 6 of 6

US Market Status

Market Closed — Opens in 6h 15m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 14, 2026